SCM
KURA icon

Suvretta Capital Management’s Kura Oncology KURA Stock Holding History

Suvretta Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.7M Hold
8,575,422
– – 1.78% 23
2025
Q4 		$89.1M Buy
8,575,422
+459,422
+6% +$4.82M 1.83% 17
2025
Q3 		$71.8M Hold
8,116,000
– – 1.84% 16
2025
Q2 		$46.8M Buy
8,116,000
+676,741
+9% +$4.15M 1.41% 27
2025
Q1 		$49.1M Buy
7,439,259
+2,362,811
+47% +$18.4M 1.82% 16
2024
Q4 		$44.2M Sell
5,076,448
-2,576,334
-34% -$37.1M 1.51% 21
2024
Q3 		$150M Buy
7,652,782
+583,155
+8% +$11.8M 4.78% 3
2024
Q2 		$146M Hold
7,069,627
– – 5.35% 4
2024
Q1 		$151M Buy
7,069,627
+123,397
+2% +$2.4M 5.6% 3
2023
Q4 		$99.9M Sell
6,946,230
-389,615
-5% -$3.83M 4.52% 5
2023
Q3 		$66.9M Buy
7,335,845
+307,403
+4% +$3.12M 3.62% 11
2023
Q2 		$74.4M Buy
7,028,442
+455,107
+7% +$5.38M 3.98% 6
2023
Q1 		$80.4M Buy
6,573,335
+196,520
+3% +$2.45M 3.4% 5
2022
Q4 		$79.1M Buy
6,376,815
+2,313,687
+57% +$33.6M 3.32% 7
2022
Q3 		$55.5M Buy
4,063,128
+46,128
+1% +$712K 2.3% 19
2022
Q2 		$73.6M Buy
4,017,000
+123,981
+3% +$1.78M 2.8% 10
2022
Q1 		$62.6M Buy
3,893,019
+320,600
+9% +$4.63M 1.91% 22
2021
Q4 		$50M Buy
3,572,419
+1,112,217
+45% +$18M 0.97% 33
2021
Q3 		$46.1M Buy
2,460,202
+801,496
+48% +$15.1M 0.78% 38
2021
Q2 		$34.6M Buy
1,658,706
+926,291
+126% +$23M 0.52% 45
2021
Q1 		$20.7M Buy
732,415
+460,915
+170% +$14.6M 0.31% 58
2020
Q4 		$8.87M Buy
271,500
+152,500
+128% +$5.36M 0.13% 63
2020
Q3 		$3.65M Buy
+119,000
New +$2.63M 0.07% 71

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Suvretta Capital Management's KURA Position: Q1 2026 in Review

Suvretta Capital Management held its Kura Oncology (KURA) position steady in Q1 2026 at 8,575,422 shares worth $69.7M. The position accounts for 1.78% of the portfolio, ranked #23.

Suvretta Capital Management first reported a position in KURA in Q3 2020 and has held it in 23 quarters since. The position peaked at $151M in Q1 2024. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Suvretta Capital Management held 8,575,422 shares of Kura Oncology worth $69.7M as of Q1 2026.
  • Suvretta Capital Management left its Kura Oncology share count unchanged in Q1 2026.
  • Kura Oncology made up 1.78% of Suvretta Capital Management's portfolio in Q1 2026, its #23 holding.
  • Suvretta Capital Management first reported a position in Kura Oncology in Q3 2020 and has held it in 23 quarters since.
  • Suvretta Capital Management's Kura Oncology position peaked at $151M in Q1 2024.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Suvretta Capital Management's 13F filing for Q1 2026, filed 15 May 2026.